Physicians Formula Holdings Inc.

Swander Pace Capital's acquisition of dietary supplement manufacturer and marketer [Swanson Health Products Inc.] could be a sign of higher interest by private equity in consumer health product firm

Financings During the third quarter of 2012, biopharma financings jumped to just over $3 billion, a 13% increase over the Q2 total. Heading the list was small-molecule cancer therapeutics developer

Following an Aug. 15 announcement that it would be bought by Swander Pace Capital , Physicians Formula Holdings Inc. has declined that offer and opted for a better deal. In a Sept. 27 release, th

IN VITRO DIAGNOSTICS Mergers & Acquisitions Danaher Corp. Beckman Coulter Inc. IRIS International Inc. Medical and industrial products manufacturer Danaher Corp. is acquiring publicly traded IRI